3v9v
From Proteopedia
(Difference between revisions)
Line 1: | Line 1: | ||
- | [[Image:3v9v. | + | [[Image:3v9v.png|left|200px]] |
- | <!-- | ||
- | The line below this paragraph, containing "STRUCTURE_3v9v", creates the "Structure Box" on the page. | ||
- | You may change the PDB parameter (which sets the PDB file loaded into the applet) | ||
- | or the SCENE parameter (which sets the initial scene displayed when the page is loaded), | ||
- | or leave the SCENE parameter empty for the default display. | ||
- | --> | ||
{{STRUCTURE_3v9v| PDB=3v9v | SCENE= }} | {{STRUCTURE_3v9v| PDB=3v9v | SCENE= }} | ||
===Crystal structure of the PPARgamma-LBD complexed with a cercosporamide derivative modulator=== | ===Crystal structure of the PPARgamma-LBD complexed with a cercosporamide derivative modulator=== | ||
- | |||
- | <!-- | ||
- | The line below this paragraph, {{ABSTRACT_PUBMED_22225641}}, adds the Publication Abstract to the page | ||
- | (as it appears on PubMed at http://www.pubmed.gov), where 22225641 is the PubMed ID number. | ||
- | --> | ||
{{ABSTRACT_PUBMED_22225641}} | {{ABSTRACT_PUBMED_22225641}} | ||
Revision as of 10:21, 8 August 2012
Crystal structure of the PPARgamma-LBD complexed with a cercosporamide derivative modulator
Template:ABSTRACT PUBMED 22225641
About this Structure
3v9v is a 2 chain structure with sequence from Homo sapiens. Full crystallographic information is available from OCA.
Reference
- Furukawa A, Arita T, Fukuzaki T, Satoh S, Mori M, Honda T, Matsui Y, Wakabayashi K, Hayashi S, Araki K, Ohsumi J. Substituents at the naphthalene C3 position of (-)-Cercosporamide derivatives significantly affect the maximal efficacy as PPARgamma partial agonists. Bioorg Med Chem Lett. 2012 Feb 1;22(3):1348-51. Epub 2011 Dec 16. PMID:22225641 doi:10.1016/j.bmcl.2011.12.066